newsfilter
← Latest News
Business Wire·

Zura Bio Announces Chief Financial Officer Transition

Zura Bio Limited (NASDAQ:ZURA) ("Zura Bio"), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases, today announced the appointment